TD Cowen Starts Intra-Cellular Therapies (ITCI) at Outperform; bullish on Caplyta growth
Tweet Send to a Friend
(Updated - December 11, 2023 6:16 AM EST)
TD Cowen analyst Joseph Thome initiates coverage on Intra-Cellular Therapies (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
TD Cowen analyst Joseph Thome initiates coverage on Intra-Cellular Therapies (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
